» Articles » PMID: 21709163

Text Mining for the Vaccine Adverse Event Reporting System: Medical Text Classification Using Informative Feature Selection

Overview
Date 2011 Jun 29
PMID 21709163
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The US Vaccine Adverse Event Reporting System (VAERS) collects spontaneous reports of adverse events following vaccination. Medical officers review the reports and often apply standardized case definitions, such as those developed by the Brighton Collaboration. Our objective was to demonstrate a multi-level text mining approach for automated text classification of VAERS reports that could potentially reduce human workload.

Design: We selected 6034 VAERS reports for H1N1 vaccine that were classified by medical officers as potentially positive (N(pos)=237) or negative for anaphylaxis. We created a categorized corpus of text files that included the class label and the symptom text field of each report. A validation set of 1100 labeled text files was also used. Text mining techniques were applied to extract three feature sets for important keywords, low- and high-level patterns. A rule-based classifier processed the high-level feature representation, while several machine learning classifiers were trained for the remaining two feature representations.

Measurements: Classifiers' performance was evaluated by macro-averaging recall, precision, and F-measure, and Friedman's test; misclassification error rate analysis was also performed.

Results: Rule-based classifier, boosted trees, and weighted support vector machines performed well in terms of macro-recall, however at the expense of a higher mean misclassification error rate. The rule-based classifier performed very well in terms of average sensitivity and specificity (79.05% and 94.80%, respectively).

Conclusion: Our validated results showed the possibility of developing effective medical text classifiers for VAERS reports by combining text mining with informative feature selection; this strategy has the potential to reduce reviewer workload considerably.

Citing Articles

The Impact of Artificial Intelligence on Allergy Diagnosis and Treatment.

Khan M, Banerjee S, Muskawad S, Maity R, Chowdhury S, Ejaz R Curr Allergy Asthma Rep. 2024; 24(7):361-372.

PMID: 38954325 DOI: 10.1007/s11882-024-01152-y.


Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug Administration.

Ball R, Talal A, Dang O, Munoz M, Markatou M J Med Internet Res. 2024; 26:e50274.

PMID: 38842929 PMC: 11190620. DOI: 10.2196/50274.


Improving long COVID-related text classification: a novel end-to-end domain-adaptive paraphrasing framework.

Somayajula S, Litake O, Liang Y, Hosseini R, Nemati S, Wilson D Sci Rep. 2024; 14(1):85.

PMID: 38168099 PMC: 10761882. DOI: 10.1038/s41598-023-48594-4.


Generalizability of machine learning methods in detecting adverse drug events from clinical narratives in electronic medical records.

Zitu M, Zhang S, Owen D, Chiang C, Li L Front Pharmacol. 2023; 14:1218679.

PMID: 37502211 PMC: 10368879. DOI: 10.3389/fphar.2023.1218679.


Automatic Extraction of Comprehensive Drug Safety Information from Adverse Drug Event Narratives in the Korea Adverse Event Reporting System Using Natural Language Processing Techniques.

Kim S, Kang T, Chung T, Choi Y, Hong Y, Jung K Drug Saf. 2023; 46(8):781-795.

PMID: 37330415 PMC: 10344995. DOI: 10.1007/s40264-023-01323-2.


References
1.
Farkas R, Szarvas G, Hegedus I, Almasi A, Vincze V, Ormandi R . Semi-automated construction of decision rules to predict morbidities from clinical texts. J Am Med Inform Assoc. 2009; 16(4):601-5. PMC: 2705267. DOI: 10.1197/jamia.M3097. View

2.
Murff H, Forster A, Peterson J, Fiskio J, Heiman H, Bates D . Electronically screening discharge summaries for adverse medical events. J Am Med Inform Assoc. 2003; 10(4):339-50. PMC: 181984. DOI: 10.1197/jamia.M1201. View

3.
Uzuner O . Recognizing obesity and comorbidities in sparse data. J Am Med Inform Assoc. 2009; 16(4):561-70. PMC: 2705260. DOI: 10.1197/jamia.M3115. View

4.
Brown E . Using MedDRA: implications for risk management. Drug Saf. 2004; 27(8):591-602. DOI: 10.2165/00002018-200427080-00010. View

5.
Vellozzi C, Broder K, Haber P, Guh A, Nguyen M, Cano M . Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine. 2010; 28(45):7248-55. DOI: 10.1016/j.vaccine.2010.09.021. View